Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Merck's Keytruda slashes death risk by 31% in esophageal cancer victory

fiercepharmaJanuary 15, 2019

Tag: Merck , Death Risk , esophageal cancer , Keytruda

PharmaSources Customer Service